You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ARESTIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Arestin patents expire, and when can generic versions of Arestin launch?

Arestin is a drug marketed by Orapharma and is included in one NDA.

The generic ingredient in ARESTIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

Drug patent expirations by year for ARESTIN
Drug Prices for ARESTIN

See drug prices for ARESTIN

Recent Clinical Trials for ARESTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bausch Health Companies, INC.Phase 4
University of Minnesota - Clinical and Translational Science InstitutePhase 4
University of MinnesotaPhase 4

See all ARESTIN clinical trials

Pharmacology for ARESTIN

US Patents and Regulatory Information for ARESTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orapharma ARESTIN minocycline hydrochloride POWDER, EXTENDED RELEASE;DENTAL 050781-001 Feb 16, 2001 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ARESTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orapharma ARESTIN minocycline hydrochloride POWDER, EXTENDED RELEASE;DENTAL 050781-001 Feb 16, 2001 ⤷  Try a Trial ⤷  Try a Trial
Orapharma ARESTIN minocycline hydrochloride POWDER, EXTENDED RELEASE;DENTAL 050781-001 Feb 16, 2001 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ARESTIN

See the table below for patents covering ARESTIN around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 03082139 ⤷  Try a Trial
Canada 2479995 DISTRIBUTEUR ET CARTOUCHE (DISPENSING APPARATUS AND CARTRIDGE) ⤷  Try a Trial
Australia 2003223384 DISPENSING APPARATUS AND CARTRIDGE ⤷  Try a Trial
Brazil 0308859 Aparelho de distribuição e cartucho ⤷  Try a Trial
Portugal 2263596 ⤷  Try a Trial
Cyprus 1114425 ⤷  Try a Trial
Colombia 5611079 APARATO DISPENSADOR Y CAPSULA ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.